PDF herunterladen
Horm Metab Res 2021; 53(10): 645-653
DOI: 10.1055/a-1587-9336
Review

Polymorphisms of Vitamin D Receptor and the Effect on Metabolic and Endocrine Abnormalities in Polycystic Ovary Syndrome: A Review

Talida Vulcan
1   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Dermatology Cluj Napoca, Romania
,
Gabriela Adriana Filip 
2   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Physiology Cluj Napoca, Romania
,
Lavinia Manuela Lenghel
3   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Radiology, Cluj Napoca, Romania
,
Tudor Suciu
4   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Maxillofacial Surgery and Radiology, Cluj Napoca, Romania
,
Paula Ilut
1   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Dermatology Cluj Napoca, Romania
,
Lucia Maria Procopciuc
5   Iuliu Hatieganu University of Medicine and Pharmacy Faculty of Medicine, Medical Biochemistry, Cluj Napoca, Romania
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorder in women of reproductive age. Vitamin D and its receptor are thought to play an important role in PCOS susceptibility, although the impact of vitamin D receptor (VDR) polymorphisms on the hormonal and metabolic profile is still controversial. A literature search in PubMed and Embase was performed up to September 2020 for case-control studies in women suffering from PCOS, with outcome related to VDR polymorphisms effect on metabolic/endocrine disturbances. We have found 16 eligible studies including 2566 women with PCOS and 2430 controls. ApaI polymorphism seemed to be associated with hyperandrogenism in both Asian and Caucasian population. FokI variant was correlated with metabolic/endocrine parameters especially in Asian population, while a relation between Cdx2 genotypes and insulin sensitivity was observed in both ethnicities. VDR polymorphisms have an important role in PCOS development and related hormonal and metabolic abnormalities. Few case-control studies analysed the interaction between VDR variants and metabolic/endocrine parameters with the majority of the articles focused on the Asian region. Further research on various ethnic populations with larger sample size are still needed for a definitive conclusion, in order to allow early diagnosis and prevention of PCOS comorbidities.

Key words

vitamin D receptor polymorphism - PCOS - hyperandrogenism - insulin resistance


Publikationsverlauf

Eingereicht: 22. Februar 2021

Angenommen nach Revision: 07. Juni 2021

Artikel online veröffentlicht:
20. September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Azziz R, Carmina E, Chen Z. et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016; 2: 1-18
    CrossrefPubMedGoogle Scholar
  • 2 Lizneva D, Suturina L, Walker W. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106: 6-15
    CrossrefPubMedGoogle Scholar
  • 3 Reis GVOP, Gontijo NA, Rodrigues KF. et al. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. J Obstet Gynaecol Res 2017; 43: 436-446
    CrossrefPubMedGoogle Scholar
  • 4 Bozdag G, Mumusoglu S, Zengin D. et al. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2016; 31: 2841-2855
    CrossrefPubMedGoogle Scholar
  • 5 Andrade VH, Mata AM, Borges RS. et al. Current aspects of polycystic ovary syndrome: a literature review. Rev Assoc Med Bras 2016; 62: 867-871
    CrossrefPubMedGoogle Scholar
  • 6 Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what's new?. Adv Clin Exp Med 2017; 26: 359-367
    CrossrefPubMedGoogle Scholar
  • 7 De Leo V, Musacchio MC, Cappelli V. et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 2016; 14: 38
    CrossrefPubMedGoogle Scholar
  • 8 Carvalho LML, Dos Reis FM, Candido AL. et al. Polycystic ovary syndrome as a systemic disease with multiple molecular pathways: A narrative review. Endocr Regul 2018; 52: 208-221
    CrossrefPubMedGoogle Scholar
  • 9 Ozdemir S, Ozdemir M, Görkemli H. et al. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand 2010; 89: 199-204
    CrossrefPubMedGoogle Scholar
  • 10 Hong JS, Kwon HH, Park SY. et al. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients. J Eur Acad Dermatol Venereol 2015; 29: 42-47
    CrossrefPubMedGoogle Scholar
  • 11 Feng JG, Guo Y, Ma LA. et al. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol 2018; 17: 511-517
    CrossrefPubMedGoogle Scholar
  • 12 Neven ACH, Laven J, Teede HJ. et al. Summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med 2018; 36: 5-12
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 13 Nyagolova PV, Mitkov MD, Orbetsova MM. Role of vitamin D and adipose tissue hormones in women with reproductive disorders. Folia Med (Plovdiv) 2015; 57: 5-10
    CrossrefPubMedGoogle Scholar
  • 14 Niu YM, Wang YD, Jiang GB. et al. Association between vitamin D receptor gene polymorphisms and polycystic ovary syndrome risk: A meta-analysis. Front Physiol 2019; 9: 1902
    CrossrefPubMedGoogle Scholar
  • 15 Liang F, Ren N, Zhang H. et al. A meta-analysis of the relationship between vitamin D receptor gene ApaI polymorphisms and polycystic ovary syndrome. Adv Clin Exp Med 2019; 28: 255-262
    CrossrefPubMedGoogle Scholar
  • 16 Wehr E, Trummer O, Giuliani A. et al. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 2011; 164: 741-749
    CrossrefPubMedGoogle Scholar
  • 17 Siddamalla S, Reddy TV, Govatati S. et al. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women. Gynecol Endocrinol 2018; 34: 161-165
    CrossrefPubMedGoogle Scholar
  • 18 Song DK, Lee H, Hong YS. et al. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: A case control study. BMC Endocr Disord 2019; 19: 145
    CrossrefPubMedGoogle Scholar
  • 19 Shi XY, Huang AP, Xie DW. et al. Association of vitamin D receptor gene variants with polycystic ovary syndrome: A meta-analysis. BMC Med Genet 2019; 20: 32
    CrossrefPubMedGoogle Scholar
  • 20 El-Shal AS, Shalaby SM, Aly NM. et al. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Rep 2013; 40: 6063-6073
    CrossrefPubMedGoogle Scholar
  • 21 Al Thomali A, Daghestani MH, Daghestani MH. et al. Polymorphic variations in VDR gene in Saudi women with and without polycystic ovary syndrome (PCOS) and significant influence of seven polymorphic sites on anthropometric and hormonal parameters. J Med Biochem 2018; 37: 415-425
    CrossrefPubMedGoogle Scholar
  • 22 Zadeh-Vakili A, Ramezani TF, Daneshpour MS. et al. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene 2013; 515: 193-196
    CrossrefPubMedGoogle Scholar
  • 23 Xavier LB, Gontijo NA, Rodrigues KF. et al. Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women. Gynecol Endocrinol 2019; 35: 146-149
    CrossrefPubMedGoogle Scholar
  • 24 Vasilovici AF, Grigore LE, Ungureanu L. et al. Vitamin D receptor polymorphisms and melanoma. Oncol Lett 2019; 17: 4162-4169
    PubMedGoogle Scholar
  • 25 Uitterlinden AG, Fang Y, Van Meurs JB. et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143-156
    CrossrefPubMedGoogle Scholar
  • 26 Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009; 92: 1381-1383
    CrossrefPubMedGoogle Scholar
  • 27 Dasgupta S, Dutta J, Annamaneni S. et al. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res 2015; 142: 276-285
    CrossrefPubMedGoogle Scholar
  • 28 Humadi EH, Showman HA, Al-azzawie RMHF. Association of vitamin-D receptor gene polymorphisms (FokI and ApaI) and vitamin D serum levels in a sample of Iraqi women with polycystic ovary syndrome. Indian J Public Health Res Dev 2018; 9: 867-874
    CrossrefPubMedGoogle Scholar
  • 29 Jedrzejuk D, Łaczmański Ł, Milewicz A. et al. Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women. Gynecol Endocrinol 2015; 31: 976-979
    CrossrefPubMedGoogle Scholar
  • 30 Szafarowska M, Dziech E, Kaleta B. et al. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome. J Assist Reprod Genet 2019; 36: 1281-1289
    CrossrefPubMedGoogle Scholar
  • 31 Dipanshu S, Chakravorty R. Genetic polymorphism in the vitamin D receptor gene and 25-hydroxyvitamin D serum levels in East Indian women with polycystic ovary syndrome. J Mol Biomark Diagn 2015; 6: 247
    PubMedGoogle Scholar
  • 32 Santos BR, Lecke SB, Spritzer PM. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: A cross-sectional study. Reprod Biol Endocrinol 2018; 16: 38
    CrossrefPubMedGoogle Scholar
  • 33 Kadhim SJ, Abdul-hassan IA. Correlation between vitamin D receptor gene polymorphisms and levels of some hormones in Iraqi infertile women with polycystic ovary syndrome. Iraqi J Biotechnol 2017; 16: 104-113
    PubMedGoogle Scholar
  • 34 Mahmoudi T, Majidzadeh-AK, Farahani H et al. Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study. Int J Reprod Biomed 2015; 13: 793–800
    PubMed
  • 35 Bagheri M, Rad IA, Jazani NH. et al. Lack of association of vitamin D receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) genetic variations with polycystic ovary syndrome risk: a case-control study from Iranian Azeri Turkish women. Maedica (Bucur) 2012; 7: 303-308
    PubMedGoogle Scholar
  • 36 Ranjzad F, Mahban A, Shemirani AI. et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2011; 28: 225-232
    CrossrefPubMedGoogle Scholar
  • 37 Ramezani N, Ostadsharif M, Nayeri H. Association of BsmI variant of vitamin D receptor gene with polycystic ovary syndrome: A case-control study. Int J Reprod BioMed 2020; 18: 877-884
    PubMedGoogle Scholar
  • 38 Bagheri M, Abdi RI, Hosseini JN. et al. Vitamin D receptor TaqI gene variant in exon 9 and polycystic ovary syndrome risk. Int J Fertil Steril 2013; 7: 116-121
    PubMedGoogle Scholar
  • 39 Hamdi RA, Abdul-Qahar ZH, Ahmed SJ. et al. Assessment of vitamin D receptor gene polymorphism in Iraqi women with polycystic ovary syndrome. J Clin Diagnostic Res 2018; 12: 27-30
    PubMedGoogle Scholar
  • 40 Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor?. Arch Biochem Biophys 2012; 523: 123-133
    CrossrefPubMedGoogle Scholar
  • 41 Szymczak-Pajor I, Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients 2019; 11: 794
    CrossrefPubMedGoogle Scholar
  • 42 Hahn S, Haselhorst U, Tan S. et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577-583
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 43 Al-Bayyari N, Al-Domi H, Zayed F. et al. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial. Clin Nutr 2021; 40: 870-878
    CrossrefPubMedGoogle Scholar